Risk of female human papillomavirus acquisition associated with first male sex partner.
about
A pilot binational study of health behaviors and immigrationProphylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsProphylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsHuman papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysisAssessing perceived risk and STI prevention behavior: a national population-based study with special reference to HPVReduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa.Prevalence, concordance and determinants of human papillomavirus infection among heterosexual partners in a rural region in central Mexico.Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerPrevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study.Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions.Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus.Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system.HPV vaccine decision making in pediatric primary care: a semi-structured interview study.Prevalence of human papillomavirus in adolescent girls before reported sexual debutIntegrating clinical, community, and policy perspectives on human papillomavirus vaccinationGuidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theHuman papillomavirus testing in the prevention of cervical cancerPractice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women.Human papillomavirus prevalence and type-distribution among women in Zhejiang Province, Southeast China: a cross-sectional study.A prospective study of absolute risk and determinants of human papillomavirus incidence among young women in Costa Rica.Factors associated with intention to vaccinate a daughter against HPV: a statewide survey in Alabama.HPV vaccination among a community sample of young adult womenThe prevalence of genital HPV and factors associated with oncogenic HPV among men having sex with men and men having sex with women and men: the HIM studyMissed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limitedThe known unknowns of HPV natural history.Referral patterns and incidence of cervical intraepithelial neoplasia in adolescent and pregnant patients: the impact of the 2006 guidelines."It All Depends": A Qualitative Study of Parents' Views of Human Papillomavirus Vaccine for their Adolescents at Ages 11-12 years.Fostering multiple healthy lifestyle behaviors for primary prevention of cancer.Prevalence of and Associated Risk Factors for High Risk Human Papillomavirus among Sexually Active Women, SwazilandNew insights into cervical cancer screening.Difficulties in estimating the male-to-female sexual transmissibility of human papillomavirus infectionPopulation-based study on the prevalence of and risk factors for human papillomavirus infection in Qujing of Yunnan province, Southwest ChinaThe implementation and acceptability of an HPV vaccination decision support system directed at both clinicians and families.Cross-sectional study on the prevalence of HPV antibodies in the general population of the Czech Republic.Natural Acquired Immunity Against Subsequent Genital Human Papillomavirus Infection: A Systematic Review and Meta-analysis.Behavioral/lifestyle and immunologic factors associated with HPV infection among women older than 45 years.Human papillomavirus vaccines: Why the time is right to implement immunization and surveillance programs in Canada.High prevalence and incidence of human papillomavirus in a cohort of healthy young African female subjectsGroup therapy as psychic containing.The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.
P2860
Q23922322-21C303FC-59FB-49CA-A724-737CBAE818FEQ24202048-AFA31DCF-2F4B-4476-9675-AACCB147E8E1Q24235373-B7576241-98B9-4852-B517-2BE2CD827B25Q26863193-B5075BBA-CEEC-4A3F-9B31-DED5600AA672Q28744019-441C41B1-B45E-4599-96D8-3B46ECA2506AQ33619797-A695EFFC-4274-4EB8-BAEA-56DC6D3409D4Q33643697-E3180290-A5FC-48FD-85C6-3D4805FFF61BQ33650105-4F4972A8-04E5-499D-B811-B44FEAAC2029Q33803206-104650FC-04BD-4828-810A-44764EB4CFE8Q33862762-0737A255-4139-45FC-ABED-101271C3D5B8Q33894441-1A9BA66E-41AB-4578-A102-AC327BC99CE7Q33918719-2047537A-34BA-46D9-AFA7-2E2140B3E59DQ34005970-B965D556-8BB0-460E-B293-66F804048C20Q34061684-6B6F9F1E-03D1-4504-8AAE-22D24CD622FFQ34078572-57342241-FD56-41F0-B104-CCCE75A17D23Q34212799-F24A03FD-CCA3-4FC4-95EE-967CC86FDB07Q34616083-C2052AB7-B68F-4BAF-8D24-4C4BA473515FQ34684543-1E31D685-9935-42F5-9459-EF8B034C2C2BQ34780744-18B22468-1B74-427C-A773-4CC659BE1ABFQ34802732-3A52BAAD-1E67-4E77-AB61-1B3B2E544002Q35000448-88BD4070-1658-44C8-84F2-FAFBB7C94F97Q35112562-C4130A30-8923-45D7-ACE4-2F58F1FBFB00Q35226408-6938070D-C1AE-4770-821A-FF5C02D75453Q35434532-9A9BD23B-EC55-43F4-8743-28222F82DD43Q35578583-426AB715-9EAF-4D30-924D-3153ED2A7F51Q35646272-A206E1B0-101D-4BAF-931E-B92C4A5CEF19Q35868164-DB113042-4EF7-48BE-A475-6F3418275CE1Q36224623-B8F4D466-75E3-415A-BF2E-52ADC73B8CA0Q36257446-EE7DCA55-3B55-47A0-AAFB-85A2CDA44AC6Q36313296-FDEF1F23-DDE3-485D-AB83-53D8C8992591Q36344953-5D69455C-5D40-4BF6-8201-89AE71AA9658Q36427407-F59836C0-D786-46AC-8CF6-D84F01F3D4A1Q36519190-B95207F3-F5BF-476C-97F3-4DC0C4A37401Q36677322-6CC96AAB-3424-4D8E-AFB9-4276E60BE5C1Q36745242-4C4A0818-9EB3-4DAF-9525-7D70B802E67CQ36988499-F0845793-E8E4-48CE-96C3-0BCC20101A0DQ37018243-139890F6-5E3D-4176-8EE9-4C80D5E3C88CQ37030821-58EEEFC6-9A86-48C7-8410-81E466BBDF90Q37197916-CA7A46DB-B91F-4C22-8785-0BD3BEA317E6Q37232535-EA12AED3-95C1-4D39-90EE-77B2FAA9B172
P2860
Risk of female human papillomavirus acquisition associated with first male sex partner.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Risk of female human papillomavirus acquisition associated with first male sex partner.
@ast
Risk of female human papillomavirus acquisition associated with first male sex partner.
@en
type
label
Risk of female human papillomavirus acquisition associated with first male sex partner.
@ast
Risk of female human papillomavirus acquisition associated with first male sex partner.
@en
prefLabel
Risk of female human papillomavirus acquisition associated with first male sex partner.
@ast
Risk of female human papillomavirus acquisition associated with first male sex partner.
@en
P2093
P2860
P356
P1476
Risk of female human papillomavirus acquisition associated with first male sex partner.
@en
P2093
James P Hughes
Laura A Koutsky
Nancy B Kiviat
Qinghua Feng
Rachel L Winer
Sandra O'Reilly
P2860
P304
P356
10.1086/524875
P407
P577
2008-01-01T00:00:00Z